Skip to main content

Table 1 Baseline Demographic and Clinical and Radiological Characteristics at Cerebral Venous Thrombosis (CVT) presentation

From: Thrombosis and bleeding outcomes in the treatment of cerebral venous thrombosis in cancer

Characteristic

N (%)

Male

25(55.6 %)

Age (years) Median, [IQR]

54.5, [41.5,62.4]

Body Mass Index (Kg/m2) Median, [IQR]

27.2, [23.4, 33.4]

Malignancy type

 Hematologic

15 (33.3 %)

 Solid

24 (53.3 %)

 Primary CNS

5 (11.1 %)

 Concurrent solid and CNS

1 (2.2 %)

Malignancy status

 Active

32 (71.1 %)

 Remission < 2 years

8 (17.8 %)

 Remission > 2 years

4 (8.9 %)

Staging (AJCC)

 1

8 (17.8 %)

 2

4 (8.9 %)

 3

5 (11.1 %)

 4

17 (37.8 %)

Active chemotherapy

20 (44.4 %)

Hormonal cancer therapy

4 (8.9 %)

Tyrosine kinase inhibitor

1 (2.2 %)

Use of ESA

1 (2.2 %)

Recent major surgery

27 (60.0 %)

Multifocal CVT

26 (57.8 %)

Occlusive CVT

14 (31.1 %)

Concurrent brain venous infarction

12 (26.7 %)

Concurrent brain parenchyma hemorrhage

16 (35.6 %)